Untitled - why apasl stc 2016?
Transcription
Untitled - why apasl stc 2016?
1 TENTATIVE COURSE PROGRAMME 22 September 2016 Murat ALADAG Ahmet GURAKAR A. Kadir DOKMECI VIRAL HEPATITIS: IMMUNEPATHOGENESIS, DIAGNOSIS AND MANAGEMENT Halis SIMSEK Ramazan IDILMAN HALL C COURSE - 3 APASL SINGLE TOPIC LIVER TRANSPLANTATION COURSE HALL B COURSE - 2 COURSE - 1 HALL A APASL - SINGLE TOPIC ENDOSCOPY COURSE Emrah ALPER SESSION 1: SESSION 1: SESSION 1: Münci KALAYOGLU Meral AKDOGAN Murat Taner GULSEN Gyongyi SZABO Halis SİMSEK Ramazan IDILMAN Reşit MISTIK Hitoshi MARUYAMA Sadettin HULAGU İbrahim Halil BAHCECIOGLU 13:00 13:20 Patient Selection and Preparation for Liver Transplantation Meral AKDOGAN 13:00 13:20 Immunity and Inflammation in Chronic HCV Infection Gyongyi SZABO 13:00 13:20 Endoscopic Management of Eosophageal Varices Abdurrahman KADAYIFCI 13:20 13:40 Living Donor Liver Transplantation in Portal Vein Trombosis Sezai YILMAZ 13:20 13:40 Non-invasive Assessment of Liver Fibrosis Levent DOGANAY 13:20 13:40 Endoscopic Management of Gastric Varices Hiroshi YATSUHASHI 13:40 14:00 LDLT or DDLT in Acute Fulminant Liver Failure Cüneyt KAYAALP 13:40 14:00 Histopathological Diagnosis of Chronic Hepatitis B and C Cenk SOKMENSUER 13:40 14:00 Therapy of Portal Cholangiopathy Hitoshi MARUYAMA 14:00 14:20 LDLT or DDLT in Hepatocellular Carcinoma Deniz BALCI 14:00 14:20 New Imaging Modalities for the Diagnosis of Liver Diseases Suna OZHAN OKTAR 14:00 14:20 TIPS: Indication, Contraindication the Impact of TIPS for Portal Hypertension Ahmet Baran ÖNAL 14:20 14:40 Coffee Break 9 TENTATIVE COURSE PROGRAMME 22 September 2016 HALL A HALL B HALL C SESSION 2: SESSION 2: TREATMENT OF CHRONIC HEPATITIS B SESSION 2: MANAGEMENT OF BILIARY DISEASES Yalçın POLAT Murat ALADAG Murat KIYICI Gamal SHIHA Hasan OZKAN Osman Cavit OZDOGAN Fehmi TABAK Toshio TSUYUGUCHI Billur CANBAKAN Cemil SAVAS Ahmet Faruk AGAN 14:40 15:00 Immunsupression in Liver Transplantation Wasim JAFRI 15:00 15:20 Pre-post Transplantation 15:00 HBV Treatment 15:20 Ramazan IDILMAN 14:40 15:00 Drug Targets on Viral Replication in the New Insight Gyongyi SZABO HBeAg (+) CHB: Treat with IFN or with Nas Jia-Horng KAO 14:40 15:00 Endoscopic Approaches in Primary Sclerosing Cholangitis Orhan TARCIN 15:00 15:20 Endoscopic Treatment of Biliary Strictures After Liver Transplantation Yaşar TUNA 15:20 15:40 Management of HCV in Developing Countries Hakan LEBLEBICIOGLU 15:20 15:40 HBeAg (-) CHB: Treat with IFN or with Nas Dinç DINCER 15:20 15:40 Endoscopic Treatment of Metastatic Cholestatic Liver Disease Toshio TSUYUGUCHI 15:40 16:00 HCC: Resection or Liver Transplantation Chul Soo AHN 15:40 16:00 HBeAg (-) CHB: Therapy and Stopping Rules Lai WEI 15:40 16:00 Percutaneous Treatment for Malingnant Strictures Murat KEKILLI 16:00 16:20 Discussion 16:00 16:20 Discussion 16:00 16:20 Discussion 16:20 16:40 10 Coffee Break TENTATIVE COURSE PROGRAMME 22 September 2016 HALL A HALL B HALL C SESSION 3: SESSION 3: TREATMENT OF CHRONIC HEAPTITIS C SESSION 3: ENDOSONOGRAPHY IN HEPATOBILIARY DISEASES Vivek KUMBHARI Ali Emre TUZUN Bülent ODEMIS Kadir AKSOZ Masao OMATA Bülent YILDIRIM Şükran KOSE Can GONEN Emrah ALPER Ahmet BEKTAS Cem KALAYCI 16:40 17:00 Post Transplant Bile Duct Problems Vivek KUMBHARI 16:40 17:00 Drugs for the Treatment of HCV: Classification, Sites of Action Ayşe AYTAMAN 16:40 17:00 Efficacy of EUS in Liver Diseases Sinan AKAY 17:00 17:20 Diagnosis and Palliative Treatment in Cholangiocarcinomas Deniz GUNEY DUMAN 17:00 17:20 Post Transplant ERCP in Difficult Cases Murat HARPUTOGLU 17:00 17:20 Treatment of HCV in the Real Word: Optimal Regimes to Offer Within the Cascade Approach Nurdan TOZUN 17:20 17:40 Post Transplant PTC Ramazan KUTLU 17:20 17:40 The Treatment of HCV, Genotype 3 Saeed HAMID 17:20 17:40 What is the Role of EUS in the Treatment of Gallstones Emrah ALPER 17:40 18:00 Prediction of Acute and the Chronic Rejection of Tranplanted Liver Murat AKYILDIZ 17:40 18:00 The Treatment of Genotype 4, 5 and 6 Alaa IBRAHIM 17:40 18:00 New Horizons in EUS Hakan SENTUK 18:00 18:20 Discussion 18:00 18:20 Discussion 18:00 18:20 Discussion Osman YÜKSEL Sebnem GURSOY 18:20 18:40 18:20 18:40 Can We Stop Nas in Patients with Chronic Hepatitis B? Alper YURCI 18:20 18:40 Where are We Now in Cholangioscopy? Toshio TSUYUGUCHI 18:40 18:50 Discussion 18:40 18:50 Discussion 18:40 18:50 Discussion 11 TENTATIVE CONGRESS PROGRAMME 23 September 2016 HALL A HALL B HALL C CHRONIC VIRAL HEPATITIS METABOLIC LIVER DISEASE IN THE PEDIATRIC PATIENTS AUTOIMMUNE HETATITIS Jia- Horng KAO Hikmet AKKIZ Yusuf UZUN Georgios LOUDIANOS Aydan KANSU Buket DALGIC Çiğdem ARIKAN Joest DRENTS Erol AVSAR Ömer TOPALAK Ender ELLIDOKUZ 08:30 08:50 Why Non-Responder? (Definition) Jia-Horng KAO 08:30 08:50 Is it Increasing or Are We Doing a Better Job? Fatih EZGU 08:30 08:50 How to Diagnose the Primary Biliary Cirrhosis Mehmet YALNIZ 08:50 09:10 What's the Molecular Mechanism of Non-Response? Gyongi SZABO 08:50 09:10 New Insight of Wilson Disease Georgios LOUDIANOS 08:50 09:10 Primary Biliary Cirrhosis Treatment; Beyond UDCA Mevlut BASKOL 09:10 09:30 Prediction and Diagnose of Non-Response? Shahab ABID 09:10 09:30 Alpha-1 Antitrypsin Deficiency Nedim HADZIC 09:10 09:30 How to Diagnose of Primary Sclerosing Cholangitis Ebubekir SENATES 09:30 09:50 Epidemiology and Burden of Non-Response in the World Simten MALHAN 09:30 09:50 Liver Storage Diseases Figen GURAKAN 09:30 09:50 Treatment of Primary Biliary Cirrhosis. What is New in the World? Cumhur DULGER 09:50 10:00 Discussion 09:50 10:00 Discussion 09:50 10:00 Discussion 10:00 10:30 Coffee Break 13 TENTATIVE CONGRESS PROGRAMME 23 September 2016 HALL A HALL B HALL C CHRONIC HEPATITIS B NASH FREE PAPERS Wasim JAFRI Abdullah SONSUZ Yücel USTUNDAG Salih HOSOGLU Zaigam ABBAS Rauf AGAYEV Ömer SENTURK Murat KEKILLI Hakan LEBLEBICIOGLU Hakan DURSUN Mustafa SUNBUL Elife ERARSLAN 10:30 10:50 The Impact of Non-Response On The Management of Chronic Hbv Infection Hikmet AKKIZ 10:30 10:50 Definition of Non-Response in NASH. Zaigam ABBAS 10:30 10:50 10:50 11:10 What Kind of Options Do We Have? (Current Management) Saeed HAMID 10:50 11:10 Two "Atypical" Forms of Nonalcoholic Fatty Liver Disease: NAFLD Without Metabolic Syndrome and Lean NAFLD Yusuf YILMAZ 10:50 11:10 11:10 11:30 New Horizons For The Treatment Of Chronic Hepatitis B George LAU 11:10 11:30 NAFLD in Non Obese People Metin BASARANOGLU 11:10 11:30 11:30 11:50 Hbe Ag Non-Seroconverter On Long Term Anti Viral Therapy Deepak AMARAPURKAR 11:30 11:50 How to Treat NAFLD Ahmet UYGUN 11:30 11:50 11:50 12:00 Discussion 11:50 12:00 Discussion 11:50 12:00 12:00 12:30 Opening Ceremony 12:30 13:00 A.Kadir DOKMECI 13:00 14:00 14 ART LECTURE The Impact of RAV on The Treatment of Chronic Hepatitis C Masao OMATA GILEAD SATELLITE SYMPOSIUM & LUNCH TENTATIVE CONGRESS PROGRAMME 23 September 2016 HALL A HALL B HALL C CHRONIC HEPATITIS D THE CHALLENGES IN HEPATATIC VASCULARY DISEASES AUTOIMMUNE HEPATIT, HCC AND BLEEDING Mario RIZETTO Halil DEGERTEKIN Yıldıran SONGUR Mustafa Kemal CELEN Jose SOLLANO Emin ALTIPARMAK Hakkı POLAT Hasmik GHAZINYAN Mehmet YUCESOY Enver DOLAR Mehmet SOKMEN Hüseyin ATASEVEN 14:00 14:20 Retreatment With Interferon In Non Responders. Fulya GUNSAR 14:00 14:20 Difficulties in Treatment of Budd Chiari Disease Jose SOLLANO 14:00 14:20 Steroid Refractory Autoimmune Hepatitis Goktug SIRIN 14:20 14:40 Longer Treatment With 14:20 Interferon As An Option. 14:40 Cihan YURDAYDIN Therapeutic Decision in Portal Vein Thrombosis Vedat GORAL 14:20 14:40 Autoimmune Hepatitis: Treatment and Outcomes Ian Homer Y. CUA 14:40 15:00 Bridging And Downstaging Treatments in Patients On the Waiting List For Transplantation Sadık BILGIC 14:40 15:00 The Treatment of Hepatic Sinusoidal Obstruction Syndrome. Alpaslan TANOGLU 15:00 15:20 New Treatment Modalities In Non-Responders Mario RIZETTO 15:00 15:20 Interventional Radiology in Hepatic Vasculary Diseases Sadık BILGIC 15:00 15:20 Interventional Endoscopic Examination in Liver Cirrhosis Fatih ASLAN 15:20 15:30 Discussion 15:20 15:30 Discussion 15:20 15:30 Discussion 14:40 15:00 The Treatment Of Co-Infection With Delta Reşat OZARAS 15:30 16:00 Coffee Break 16:00 17:00 ABBVIE SATELLITE SYMPOSIUM 15 TENTATIVE CONGRESS PROGRAMME 23 September 2016 HALL A HALL B SPECIAL POPULATIONS IN CHB ALCOHOLIC LIVER DISEASES Tarık ASSELAH M. Hadi YASA Kendal YALCIN Gülbanu CANBALOGLU ERKAN Rino GANI Ayşegül OZAKYOL Yaşar NAZLIGUL Fatih ALBAYRAK HALL C HCV Belkıs UNSAL İsmail BALIK Bilgehan AYGEN Neşe IMERYUZ 17:00 17:20 Pregnancy and Lactation Nevin YILMAZ 17:00 17:20 What To Do in Non-Responders Of Acute Alcoholic Hepatitis Dong Joon KIM 17:00 17:20 Non Response During DAAs Era Lai WEI 17:20 17:40 Immunocompromised Patients Bülent DEGERTEKIN 17:20 17:40 Treatment For Chronic Alcoholic Cholestatic Disease Yusuf YAZGAN 17:20 17:40 The Treatment of HCV in Special Populations Necati ORMECI 17:40 18:00 Factors Associated With Non-Responders of Hepatitis B,C and Delta, in Pakistan. Shahab ABID 17:40 18:00 Chronic Renal Failure Tevfik ECDER 17:40 18:00 Challenges In Liver Transplantation of Alcoholic Cirrhosis Diana A. PAYAWAL 18:00 18:20 Co-infection Tarık ASSELAH 18:00 18:20 Imaging and New Treatment Modality of HCC (CCC) Shuichiro SHIINA 18:00 18:20 The Treatments With Inhibitors of Cell Entrance in Chronic HCV Infection Che COLPITTS 18:20 18:30 Discussion 18:20 18:30 Discussion 18:20 18:30 Discussion Mohammed Hossein SOMI 18:30 18:50 16 A Novel Immune Therapy for Chronic Hepatitis B: Relevance to Reduction of NonResponder of Present Therapeutic Options Fazle AKBAR Enver ZEREM 18:30 18:50 18:30 18:50 Hepathopulmonary and Porthopulmonary Syndromes, Diagnoses and Treatments Ahmet GURAKAR TENTATIVE CONGRESS PROGRAMME 24 September 2016 HALL A HALL B HALL C CHRONIC HEPATITIS C HCC FREE PAPERS Tarık ASSELAH Necati ORMECI İftihar KOKSAL Macit GULTEN Shuichiro SHIINA Bülent KANTARCEKEN Ömer SENTURK Dursun Kadir BAHAR Oidov BAATATKHUU Necati YENICE Fuat EKIZ İlker TURAN 08:30 08:50 Primary Antiviral Resistance; Is It Clinically Important Tarık ASSELAH 08:30 08:50 Best Treatment Option in HCC; Ablation, Resection or Transplantation? Shuichiro SHIINA 08:30 08:50 08:50 09:10 Current Treatment of CHC in Terms of Guide-lines Ayşe AYTAMAN 08:50 09:10 Predictions of Recurrence and Prevention of Recurrence, How? Hikmet AKKIZ 08:50 09:10 09:10 09:30 Management of Direct Acting Antivirals Treatment Failure Wasim JAFRI 09:10 09:30 Management of Patients with Recurrent Hepatocellular Carcinoma Salim DEMIRCI 09:10 09:30 09:30 09:50 The Situation of IFN Free Treatment in Chronic HCV Osamu YOKOSUKA 09:30 09:50 When the Palliative Chemotherapy is an Option? Şuayib YALCIN 09:30 09:50 09:50 10:00 Discussion 09:50 10:00 Discussion 09:50 10:00 10:00 10:30 18 Coffee Break TENTATIVE CONGRESS PROGRAMME 24 September 2016 HALL A HALL B HALL C ACUTE ON CHRONIC LIVER FAILURE AUTOIMMUNE LIVER DISEASES FREE PAPERS Shiv SARIN Sabahattin KAYMAKOGLU Mehmet IBIS Osman YUKSEL Joest DRENTS Sait BAGCI Cemil SAVAS Nihat OKCU Salimur RAHMAN Metin UZMAN Beytullah YILDIRIM Birol BAYSAL 10:30 10:50 Definition of ACLF A.Kadir DOKMECI 10:30 10:50 Treatment of Autoimmune Hepatitis Together with Chronic HBV or HCV Joest DRENTS 10:50 11:10 Acute Insult of ACLF Mamun Al MAHTAB 10:50 11:10 The Treatment of Acute Fulminant Autoimmune Hepatitis Gamal SHIHA 10:50 11:10 11:10 11:30 Acute Kidney Injury in ACLF Yogesh CHAWLA 11:10 11:30 The treatment of Autoimmune Liver Cirrhosis Ahmet GURAKAR 11:10 11:30 11:30 11:50 Therapy of ACLF Shiv SARIN 11:30 11:50 The Non-response in Overlap and Outlier Syndromes Ömer OZBAKIR 11:30 11:50 11:50 12:00 Discussion 11:50 12:00 Discussion 11:50 12:00 10:30 10:50 Discussion 12:00 12:30 CONFERENCE: Hasan OZKAN- Shiv SARIN 12:30 13:00 Okuda Lectures: Necati ORMECI Stemcell Transplantation: Stephen STROM 13:00 14:00 LUNCH & SATELLITE SYMPOSIUM 19 TENTATIVE CONGRESS PROGRAMME 24 September 2016 HALL A HALL B HALL C TRANSPLANTATION NON-RESPONSE IN LIVERRELATED COMPLICATIONS VIRAL HEPATITIS B, C, D Alaa IBRAHIM Murat ALADAG Mamun Al MAHTAB Çetin KARACA Barjesh C SHARMA Mehmet ARSLAN Filiz AKYUZ Ali DEMIR Shahab ABID Celal ULASOGLU Rahmet GUNER Kenan HIZEL 14:00 14:20 Pre and Post Liver Tx HBV Treatment ; HBIG Prophylaxis Tatsua KANDA 14:00 14:20 The Treatment of HBV in Special Populations Meltem ERGUN 14:20 14:40 Management of Cirrhotic Refracter Ascitis İnci SULEYMANLAR 14:20 14:40 The Treatment of HBV in Haematologic Disorders George LAU 14:40 15:00 Minimal Hepatic Encephalopathy, Shoud We treat or Not Barjesh C SHARMA 14:40 15:00 Management of HBV in Pregnancy Yasemin BALABAN 15:00 15:20 Management of Pre and Post Transplanted Patients with Chronic HCV Ahmet GURAKAR 15:00 15:20 Approach to Patient with Resistant Hyponatremia Seyfettin KOKLU 15:00 15:20 The Clinical Utility of HBsAg Quantification in the Natural Course of Chronic Hepatitis B Hasan OZKAN 15:20 15:30 Discussion 15:20 15:30 Discussion 15:20 15:30 Discussion 14:00 14:20 Management of Cirrhotic Ascites Mehmet ARHAN 14:20 14:40 Treatment of Rejection in Patients with Steroid Resistant Chandan KUMAR 14:40 15:00 Biliary Complications in Post-Transplant Patients İrfan KORUK 15:30 16:00 Coffee Break 16:00 17:00 SATELLITE SYMPOSIUM 20 TENTATIVE CONGRESS PROGRAMME 24 September 2016 HALL A HALL B HALL C PRESIDENT’S CHOICES CASE PRESENTATIONS THE TREATMENT OF CIRRHOSIS COMPLICATIONS Nihat OKCU Necla TULEK Arif Mansur COSAR Altuğ SENOL M.Kürşat TURKDOGAN Celal AYAZ Ramazan KURT Ahmet UYANIKOGLU Kadri GUVEN Cem KOCKAR Ali Tüzün INCE Hakan YUCEYAR 17:00 17:20 17:00 17:20 17:00 17:20 The Non-response to Treatment with Terlipressin and Albumin in Hepatorenal Syndrome Salimur RAHMAN 17:20 17:40 17:20 17:40 17:20 17:40 The Non-response to Vasoactive Therapy in Variceal Bleeding Sahin COBAN 17:40 18:00 17:40 18:00 17:40 18:00 The Treatment of Spontan Bacterial Peritonitis Hakan ERDEM 18:00 18:20 The Treatment of Portal Hypertensive Gastroenteropathy in Liver Cirrhosis Tuğrul PURNAK 18:20 18:30 Discussion 18:30 19:10 CONFERENCE: How Can We Predict Future About HCV Homie RAZAVI 18:00 18:20 18:20 18:30 18:00 18:20 Discussion 18:20 18:30 Discussion Laurentius A. LESMANA 18:30 19:10 CONFERENCE: Acute Liver Failure How to Treat Ayse AYTAMAN Wan-Long CHUANG 18:30 19:10 Diagnostic Approach for Non-Alcoholic Fatty Liver Disease Amna Subhan BUTT Laurentius A. LESMANA Muammer KARA 21